PDEX on Nasdaq

PRO DEX INC

PRO DEX INC is a surgical and medical instruments and apparatus company, listed on Nasdaq (PDEX).1 It is headquartered in Irvine, California.1

Price unavailable

Last updated Oct 20, 2026.

Overview

$77.5MRevenue, fiscal 20262
$13.7MNet income, fiscal 20262

Compare with Sight Sciences, Inc., TELA Bio, Inc. or IRADIMED CORP, or pick any stock.

  • TickerPDEX on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersIrvine, California1
  • Business address2361 Mcgaw Avenue, Irvine, Ca 926143
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

31.4%Gross margin2
16.8%Operating margin2
17.6%Net margin2
16.5%Revenue growth, 20262
28.7%Return on equity2
0.37×Debt to equity2
$6.8MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue64¢$53.2M
  • Research and development4¢$3.3M
  • Selling, general and admin10¢$8.0M
  • Income tax5¢$4.4M
  • Profit17¢$13.7M

Out of $77.5M in revenue.2

Where each dollar of operating cash went, fiscal 2026

  • Capital spending7¢$483.0K
  • Share buybacks47¢$3.4M
  • Kept or used elsewhere46¢$3.4M

Out of $7.2M of cash from operations.2

Financial statements

Revenue567892$77.5M in 2026+185% since 2019
0$20.0M$40.0M$60.0M$80.0M2019: $27.2M$27.2M20192020: $34.8M$34.8M2020+28%2021: $38.0M$38.0M2021+9%2022: $42.0M$42.0M2022+11%2023: $46.1M$46.1M2023+10%2024: $53.8M$53.8M2024+17%2025: $66.6M$66.6M2025+24%2026: $77.5M$77.5M2026+16%
Gross profit567892$24.3M in 2026+149% since 2019
0$10.0M$20.0M$30.0M2019: $9.8M$9.8M20192020: $13.1M$13.1M2020+34%2021: $13.6M$13.6M2021+3%2022: $13.1M$13.1M2022−3%2023: $12.7M$12.7M2023−3%2024: $14.6M$14.6M2024+14%2025: $19.5M$19.5M2025+34%2026: $24.3M$24.3M2026+25%
Operating income567892$13.0M in 2026+160% since 2019
0$5.0M$10.0M$15.0M2019: $5.0M$5.0M20192020: $7.1M$7.1M2020+41%2021: $4.5M$4.5M2021−36%2022: $5.1M$5.1M2022+13%2023: $5.8M$5.8M2023+12%2024: $7.2M$7.2M2024+24%2025: $10.7M$10.7M2025+49%2026: $13.0M$13.0M2026+22%
Net income567892$13.7M in 2026+229% since 2019
0$5.0M$10.0M$15.0M2019: $4.1M$4.1M20192020: $6.1M$6.1M2020+47%2021: $6.2M$6.2M2021+1%2022: $4.6M$4.6M2022−26%2023: $7.1M$7.1M2023+55%2024: $2.1M$2.1M2024−70%2025: $9.0M$9.0M2025+322%2026: $13.7M$13.7M2026+52%

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2026-06-302025-06-30
Net sales$77.5M$66.6M
Cost of sales$53.2M$47.1M
Gross profit$24.3M$19.5M
Selling, general and administrative expenses$8.0M$5.2M
Research and development costs$3.3M$3.6M
Total operating expenses$11.3M$8.8M
Operating income$13.0M$10.7M
Interest and dividend income$181.0K$82.0K
Gain on marketable equity investments, net$5.7M$2.1M
Interest expense-$812.0K-$829.0K
Total other income$5.0M$1.4M
Income before income taxes$18.0M$12.1M
Income tax expense-$4.4M-$3.1M
Net income$13.7M$9.0M
Basic net income per share$4.24$2.73
Diluted net income per share$4.12$2.67
Basic3.2M shares3.3M shares
Diluted3.3M shares3.4M shares

Compare PRO DEX INC with another company

Corporate structure

PRO DEX INC sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of PRO DEX INC

  • Nicholas John Swenson Filed SCHEDULE 13D/A on PRO DEX INC, latest Jun 26, 2026
  • AO Partners I, LP Filed SCHEDULE 13D/A on PRO DEX INC, latest Apr 4, 2025
  • FARNAM STREET PARTNERS LP /MN Filed SCHEDULE 13D/A on PRO DEX INC, latest Mar 27, 2025 (2 filings since Jan 29, 2025)
  • PRO DEX INC Irvine, California
    • Advanced Precision Machining, LLC Subsidiary · California, United States
    • PDEX Franklin LLC Subsidiary · California, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What PRO DEX INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$17.0M2 Jun 30, 2026$15.5M2 Jun 30, 2025+9.4%
Accumulated depreciation$11.6M2 Jun 30, 2026$10.3M2 Jun 30, 2025+12.0%
Property and equipment, net$5.4M2 Jun 30, 2026$5.2M2 Jun 30, 2025+4.3%
Operating-lease assets (leased space)$602.0K2 Jun 30, 2026$1.1M2 Jun 30, 2025−42.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$8.2M2 Jun 30, 2026$419.0K2 Jun 30, 2025+1855.1%
Marketable securities, current$1.1M2 Jun 30, 2026$6.7M2 Jun 30, 2025−82.9%
Marketable securities, non-current$154.0K2 Jun 30, 2026$148.0K2 Jun 30, 2025+4.1%
Long-term investments$504.0K2 Jun 30, 2026$148.0K2 Jun 30, 2025+240.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$6.5M2 Jun 30, 2026$112.0K15 Jun 30, 2017+5725.9%
Intangible assets, net (excluding goodwill)$686.0K2 Jun 30, 2026$26.0K2 Jun 30, 2025+2538.5%
Accumulated amortization$242.0K2 Jun 30, 2026$182.0K2 Jun 30, 2025+33.0%
Finite-lived intangibles, net$686.0K2 Jun 30, 2026$26.0K2 Jun 30, 2025+2538.5%
Patents, net$928.0K2 Jun 30, 2026$208.0K2 Jun 30, 2025+346.2%

Inventory

ItemLatestA year beforeChange
Inventory, total$21.5M2 Jun 30, 2026$22.2M2 Jun 30, 2025−3.4%
Raw materials$9.2M2 Jun 30, 2026$10.4M2 Jun 30, 2025−11.3%
Work in process$7.7M2 Jun 30, 2026$7.4M2 Jun 30, 2025+3.7%
Finished goods$1.9M2 Jun 30, 2026$1.5M2 Jun 30, 2025+23.2%

Properties, in its own words

Our executive offices and manufacturing facility are located at 2361 McGaw Avenue, Irvine, California 92614. We lease the 28,000 square foot facility from an unrelated third party at a current base monthly lease rate of approximately $45,000 with 3% annual escalations through the expiration of the lease in September 2027. The building is a one-story, stand-alone structure of concrete “tilt-up” construction, approximately 45 years old and in good condition.

Our Franklin Property, located at 14401 Franklin Avenue, Tustin, California 92780, is used primarily for our assembly and repairs operations. We purchased this 25,000 square foot facility in November 2020 from an unrelated third party, with the majority of the purchase price financed by a property loan (See Notes 6 and 9 of the consolidated financial statements contained elsewhere in this report). The building is a one-story, stand-alone structure of concrete “tilt-up” construction, approximately 45 years old and in good condition.

The rest of Item 2

Our APM facility located at 1649 Monrovia Avenue, Costa Mesa, California 92627 is represented by three approximately 2,500 square foot adjacent facilities leased from an unrelated third party at a lease rate of approximately $17,000 per month through December 31, 2026.

We believe that our facilities are adequate for our current and expected future needs and are in full compliance with applicable state, EPA and other agency environmental standards.

Item 2 of the 10-K filed Sep 3, 2026.16

Leadership

Who has led PRO DEX INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Mark Phillip Murphy2007–2011
  2. Michael J. Berthelot2012
  3. Harold A. Hurwitz2014
  4. Kirk Richard Lee Van Jr.2015–now

President

  1. Michael J. Berthelot2012

Chief financial officer

  1. Jeffrey J. Ritchey2006–2009
  2. Harold A. Hurwitz2010–2014
  3. Alisha Charlton2015–now

Chief operating officer

  1. Kirk Richard Lee Van Jr.2013–2014
2010201520202025
Board members and other officers (15)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Advanced Precision Machining, LLC California4
  • PDEX Franklin LLC California4

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

  1. Sep 18, 20268-K Entered a material agreement37
  2. Sep 3, 20268-K Results of operations38
  3. Aug 28, 20268-K Executive or director change39
  4. Jun 17, 20268-K Regulation FD disclosure40
  5. Apr 30, 20268-K Results of operations41
  6. Mar 27, 20268-K Executive or director change42
  7. Feb 12, 20268-K Entered a material agreement; Completed an acquisition or sale; New debt or obligation43
  8. Jan 29, 20268-K Results of operations44
  9. Dec 19, 20258-K Executive or director change; Other events45
  10. Nov 21, 20258-K Executive or director change; Shareholder vote46
  11. Oct 30, 20258-K Results of operations47
  12. Sep 4, 20258-K Results of operations48
  13. May 29, 2015New chief executive Kirk Richard Lee Van Jr. becomes CEO17
  14. May 1, 2014New chief executive Harold A. Hurwitz becomes CEO18
  15. Nov 8, 2012New chief executive Michael J. Berthelot becomes CEO19
  16. Feb 22, 2007New chief executive Mark Phillip Murphy becomes CEO20

Calendar

Coming up

  1. Oct 29, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.62 a share, on Oct 30, 2025.49

When it reported results

  1. Sep 3, 2026Reported quarterly or annual results38
  2. Apr 30, 2026Reported quarterly or annual results41
  3. Jan 29, 2026Reported quarterly or annual results44
  4. Oct 30, 2025Reported quarterly or annual results47
  5. Sep 4, 2025Reported quarterly or annual results48
  6. May 1, 2025Reported quarterly or annual results50
  7. Jan 30, 2025Reported quarterly or annual results51
  8. Oct 31, 2024Reported quarterly or annual results52

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

172 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 49 major events, 66 insider forms, 5 large holders, 32 other. The latest 20:

  1. Oct 6, 2026ARS EDGAR
  2. Oct 6, 2026DEFA14A DEFINITVE 14A ADDITIONAL MATERIALS EDGAR
  3. Oct 6, 2026DEF 14A PROXY STATEMENT EDGAR
  4. Sep 18, 20268-K EDGAR
  5. Sep 14, 20264 EDGAR
  6. Sep 10, 20264 EDGAR
  7. Sep 10, 20264 EDGAR
  8. Sep 9, 2026144 EDGAR
  9. Sep 8, 2026144 EDGAR
  10. Sep 3, 20268-K EDGAR
  11. Sep 3, 202610-K ANNUAL REPORT EDGAR
  12. Aug 28, 20268-K EDGAR
  13. Jul 24, 20264 EDGAR
  14. Jul 14, 20264 EDGAR
  15. Jul 6, 20264 EDGAR
  16. Jul 6, 20264 EDGAR
  17. Jul 6, 20264 EDGAR
  18. Jun 26, 2026SCHEDULE 13D/A EDGAR
  19. Jun 17, 20268-K EDGAR
  20. Jun 1, 2026SD EDGAR

The 172 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

35 open-market trades by officers, directors and large owners since October 2021: 2 buys and 33 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 11, 2026Van Kirk Richard Lee JrChief Executive OfficerSale765$59.36$45.4KForm 4
Sep 9, 2026Van Kirk Richard Lee JrChief Executive OfficerSale19,235$60.58$1.2MForm 4
Sep 9, 2026Charlton AlishaChief Financial OfficerSale2,300$61.30$141.0KForm 4
May 22, 2026Van Kirk Richard Lee JrChief Executive OfficerSale4,128$62.36$257.4KForm 4
May 21, 2026Van Kirk Richard Lee JrChief Executive OfficerSale5,872$62.81$368.8KForm 4
Mar 16, 2026Domingo Angelita RebamontanDirectorSale998$47.24$47.1KForm 4
Apr 2, 2025Swenson Nicholas JohnDirectorSale4,526Form 4
Apr 1, 2025CABILLOT RAYMOND EDirectorSale7,263$50.01$363.2KForm 4
Mar 31, 2025CABILLOT RAYMOND EDirectorSale836$50.00$41.8KForm 4
Mar 28, 2025CABILLOT RAYMOND EDirectorSale842$50.00$42.1KForm 4
Mar 26, 2025CABILLOT RAYMOND EDirectorSale3,096$50.13$155.2KForm 4
Mar 25, 2025CABILLOT RAYMOND EDirectorSale12,927$50.28$650.0KForm 4
Mar 24, 2025CABILLOT RAYMOND EDirectorSale2,784$50.00$139.2KForm 4
Mar 20, 2025FARNAM STREET PARTNERS LP /MN10% ownerSale1,101$50.00$55.0KForm 4
Mar 19, 2025FARNAM STREET PARTNERS LP /MN10% ownerSale1,000$50.00$50.0KForm 4
Mar 14, 2025CABILLOT RAYMOND EDirectorSale5,151$50.00$257.6KForm 4
Mar 11, 2025CABILLOT RAYMOND EDirectorSale5,132$45.06$231.2KForm 4
Mar 10, 2025CABILLOT RAYMOND EDirectorSale7,674$45.00$345.3KForm 4
Jan 30, 2025FARNAM STREET PARTNERS LP /MN10% ownerSale1,100$45.01$49.5KForm 4
Jan 28, 2025CABILLOT RAYMOND EDirectorSale5,381$41.64$224.1KForm 4

All 35 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2026Richard L. Van Kirk66$350.0K$727.6K56
2026Alisha K. Charlton$249.8K$353.7K56
2025DirectorCEO, President and COO$350.0K$653.0K56
2025Chief Financial Officer$247.2K$357.8K56

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 67. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.153,178$9.0M0.0%+663
Vanguard Capital Management LLC82,283$4.8M0.0%−29,047
Dimensional Fund Advisors LP57,061$3.3M0.0%+120
Punch & Associates Investment Management, Inc.52,735$3.1M0.2%−9,000
Geode Capital Management, LLC49,636$2.9M0.0%+1,289
Jpmorgan Chase & Co32,287$1.9M0.0%+251
State Street Corp31,310$1.8M0.0%−1,804
Goldman Sachs Group Inc18,711$1.1M0.0%+8,570
Pekin Hardy Strauss, Inc.16,500$966.1K0.1%New
Bnp Paribas Financial Markets15,945$933.6K0.0%+2,711
Northern Trust Corp15,615$914.3K0.0%−31,076
Vanguard Portfolio Management LLC14,332$839.1K0.0%+1,895
LPL Financial LLC14,297$837.1K0.0%+1,237
Jane Street Group, LLC13,638$798.5K0.0%New
Vanguard Fiduciary Trust Co13,300$778.7K0.0%+232
Bank of New York Mellon Corp11,587$678.4K0.0%+528
Corsair Capital Management, L.P.10,835$634.4K0.1%No change
Bard Associates Inc9,799$573.7K0.1%−767
Nuveen, LLC9,247$541.4K0.0%+4,250
Osaic Holdings, Inc.9,060$530.5K0.0%−2,514
Morgan Stanley8,664$507.3K0.0%−5,549
XTX Topco Ltd7,950$465.5K0.0%New
Charles Schwab Investment Management Inc7,081$414.6K0.0%+588
Morgan Dempsey Capital Management LLC6,716$393.7K0.2%+908
First Trust Advisors LP5,934$347.4K0.0%+225

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How PRO DEX INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPRO DEX INC1
  • CIK0000788920
  • Employer ID (EIN)84-126124016
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company16
  • Incorporated inColorado16
  • Fiscal year endsJune 301
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address2361 Mcgaw Avenue, Irvine, CA 926141
  • Phone949-769-32311
  • Shares outstanding3,203,334 shares as of Sep 2, 202616
  • Public float$67.8M as of Dec 31, 202516
  • AuditorBaker Tilly US, LLP, Irvine, California PCAOB ID 23; no auditor attestation of internal control over financial reporting16
  • On EDGAR sinceNov 3, 19951
  • Filings1,024 in all: 4 (343), 8-K (270), 10-Q (57), 10QSB (36), DEF 14A (30), SC 13D/A (29), UPLOAD (25), 10-K (18)1
    All 46 form types

    CORRESP (18), DEFA14A (18), 3 (14), SC 13G/A (14), 144 (13), SD (13), 5 (12), 10KSB (11), 4/A (11), 10-K/A (9), 8-K/A (7), S-8 (7), SC 13G (7), DFAN14A (6), 10KSB/A (5), 10-Q/A (4), PRE 14A (4), SCHEDULE 13D/A (4), DEFR14A (3), EFFECT (3), NT 10-K (3), S-3 (3), S-3/A (3), SC 13D (3), 10KSB40 (2), 10QSB/A (2), 424B5 (2), DEFC14A (2), NT 10-Q (2), PREC14A (2), PRRN14A (2), 3/A (1), 424B3 (1), ARS (1), CT ORDER (1), DEF 14C (1), PRER14A (1), S-8 POS (1)

  • Latest filingsAnnual report (10-K) Sep 3, 2026
    Quarterly report (10-Q) Apr 30, 2026
    Proxy statement (DEF 14A) Oct 6, 2026
    Latest 8-K (8-K) Sep 18, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, no par valuePDEXNASDAQ

From the cover page of the 10-K filed Sep 3, 2026 (Section 12(b) of the Exchange Act).16

Risk factors and legal proceedings

The risks PRO DEX INC names in Item 1A of its 10-K filed Sep 3, 2026: 24 risks under these headings, as written.16

  • Risks Related to Our Business and the Industry in Which We Operate
  • A substantial portion of our revenue is derived from a few customers. If we were to lose a key customer, it would have a material adverse effect on our business, financial condition, and results of operations.
  • A substantial portion of our business is derived from our core business area that, if not serviced properly, may result in a material adverse impact upon our business, financial condition, and results of operations.
  • Our customers may cancel or reduce their orders, change production quantities, or delay production, any of which would reduce our sales and adversely affect our results of operations.
  • In recent years, we have launched several new medical device products and our estimates of warranty claims are based largely on our previous history from similar legacy products. If actual warranty claims exceed our estimates, it could have an adverse effect on our results of operations and financial condition.
  • We face significant competition from a number of different sources, which could negatively impact our results of operations.
  • The industry in which we operate is subject to significant technological change and any failure or delay in addressing such change could adversely affect our competitive position or could make our current products obsolete.
  • We rely heavily on our proprietary technology, which, if not properly protected or if deemed invalid, could have a material adverse effect on our business, financial condition, and results of operations.
  • If our technology infrastructure is compromised, damaged or interrupted by a cybersecurity incident, data security breach or other security problems, our results of operations and financial condition could be adversely affected.
  • To service our debt obligations, we will require a significant amount of cash. However, our ability to generate cash depends on many factors beyond our control.
  • Our cash and cash equivalents may be exposed to banking institution risk.
  • We periodically invest surplus cash in marketable securities and other investments in order to realize a positive return, although there can be no assurance that a positive return will be realized, and we could lose some or all of our investments, which could adversely affect our financial condition and results of operation.
The other 13 risks
  • Our operations are dependent upon our key personnel. If such personnel were to leave unexpectedly, we may not be able to execute our business plan.
  • We may not be able to successfully integrate our business acquisitions, which could adversely affect our business, financial condition, and results of operations.
  • We have experienced losses in the past, and we cannot be certain that we will sustain our current profitability; we may need additional capital in the future to fund our businesses, which we may not be able to obtain on acceptable terms.
  • Risks Related to Ownership of Our Common Stock
  • Two of our directors hold voting power with respect to a substantial portion of our outstanding common stock that enables them to have significant influence over the outcome of all matters submitted to our shareholders for approval, which influence may conflict with our interests and the interests of other shareholders.
  • Our quarterly results can fluctuate significantly from quarter to quarter, which may negatively impact the price of our shares and/or cause significant variances in the prices at which our shares trade.
  • Regulatory & Compliance Risks
  • Our operations are subject to a number of complex government regulations, the violation of which could have a material adverse effect on our business.
  • We face risks and uncertainties associated with potential litigation by or against us, which could have a material adverse effect on our business, financial condition, and results of operations.
  • The agreements governing our various debt obligations impose restrictions on our business and could adversely affect our ability to undertake certain corporate actions.
  • We are subject to changes in and interpretations of financial accounting matters that govern the measurement of our performance, compliance with which could be costly and time-consuming.
  • Our evaluation of internal controls and remediation of potential problems is costly and time-consuming and we have previously identified material weaknesses in our internal control over financial reporting. Failure to achieve and maintain effective internal control over financial reporting could materially and adversely affect our business, results of operations, financial condition, and stock price.
  • Our acquisition of APM may increase our exposure to complex export control and government contracting requirements, the violation of which could have a material adverse effect on our business.
  • General Risks
  • The global economic environment may impact our business, financial condition, and results of operations.
  • Tariffs could have a negative effect on our business, results of operations, financial condition, and liquidity.

Legal proceedings

See Note 11 to the consolidated financial statements contained elsewhere in this report.

The opening of Item 3, Legal Proceedings.16

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56